As Pozen (Nasdaq: POZN) turns to the next chapter as a company, it will look to hire a sales force and establish relationships with cardiologists.
This will allow it to first sell the already approved drug Fibricor and set the table to sell Yosprala, which Pozen hopes will soon receive FDA approval.
Since the beginning of June, the company has dropped some bombs.
Help employers find you! Check out all the jobs and post your resume.
This will allow it to first sell the already approved drug Fibricor and set the table to sell Yosprala, which Pozen hopes will soon receive FDA approval.
Since the beginning of June, the company has dropped some bombs.
Help employers find you! Check out all the jobs and post your resume.
